Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0001193125-25-309751

Director sold 5,000 shares at $138.64 ($693,200)

  • Director acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Weill David · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-03 Exercise or conversion : show line 1 in the form +5,000 $14.20 $71,000 17,134 D
2025-12-03 Sale : show line 2 in the form −5,000 $138.64 $693,200 12,134 D
Open-market sales · 5,000 sh · avg $138.64 · $693,200

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-03 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −5,000 5,000 D
Loading xslF345X05/ownership.xml…